Curcumin reverses attenuated carbachol-induced contraction of the colon in a rat model of colitis

Scandinavian Journal of Gastroenterology

Volumn 44, Issue 2, 2009, Pages 187-194

  Lubbad, Asmaa S ^a   Oriowo, Mabayoje A ^a   Khan, Islam ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Colitis; Contractility; Curcumin; TNBS

Indexed keywords

CARBACHOL; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MYELOPEROXIDASE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; COLITIS; COLON; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; DRUG SENSITIVITY; ENZYME ACTIVITY; EXPERIMENTAL RAT; HISTOPATHOLOGY; INFLAMMATORY CELL; INTESTINE CONTRACTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CARBACHOL; COLITIS; COLON; CURCUMIN; DISEASE MODELS, ANIMAL; MALE; MUSCLE CONTRACTION; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 61649084005     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520802449302     Document Type: Article

References (39)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
2. Odashima M, Otaka M, Jin M, Horikawa Y, Matsuhashi T, Ohba R, et al. Successful treatment of refractory duodenal Crohn's disease with infliximab. Dig Dis Sci 2007;52:31-2.
3. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, Serraino I, Britti D, et al. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 2002;135:496-510.
4. Fröde-Saleh TS, Calixto JB. Synergistic antiinflammatory effect of NF kappaB inhibitors and steroidal or non-steroidal antiinflammatory drugs in the pleural inflammation induced by carrageenan in mice. Inflamm Res 2000;49:330-7.
5. Sanchez-Hidalgo M, Martin AR, Villegas I, Alarcon de la Lastra C. Rosiglitazone, a PPARg ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Eur J Pharmacol 2007;562:247-58.
6. Sugimoto K, Hanai H, Tozawa K, Aoshi T, Uchijima M, Nagata T, Koide Y. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 2002;123:1912-22.
7. Ukil A, Maity S, Karmakar S, Datta N, Vedasiromoni JR, Das PK. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br J Pharmacol 2003;139:209-18.
8. Jian YT, Mai GF, Wang JD, Zhang YL, Luo RC, Fang YX. Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rat colitis induced by trinitrobenzene sulfonic acid. World J. Gastroenterol 2005;11:1747-52.
9. Salh B, Assi K, Templeman V, Parhar K, Owen D, Gomez-Munoz A, et al. Curcumin attenuates DNB-induced murine colitis. Am J. Physiol 2003;285:G235-43.
10. Venkataranganna MV, Rafiq M, Gopumadhavan S, Peer G, Babu UV, Mitra SK. NCB-02 (standardized Curcumin preparation) protects dinitrochlorobenzene- induced colitis through down-regulation of NFkappa-B and iNOS. World J Gastroenterol 2007;13:1103-7.
11. Deguchi Y, Andoh A, Inatomi O, Yagi Y, Bamba S, Araki Y, et al. Curcumin prevents the development of dextran sulfate sodium (DSS)-induced experimental colitis. Dig Dis Sci 2007;52:2993-8.
12. Fox-Robichaud AE, Collins SM. Altered calcium-handling properties of jejunal smooth muscle from the nematode-infected rat. Gastroenterology 1986;91:1462-9.
13. Grossi L, McHugh K, Collins SM. On the specificity of altered muscle function in experimental colitis in rats. Gastroenterology 1993;104:1049-56.
14. Khan I, Oriowo MA, Anim JT. Amelioration of experimental colitis by Na-H exchanger-1 inhibitor amiloride is associated with reversal of IL-1β and ERK mitogen activated protein kinase. Scand J Gastroenterol 2005;40:578-85.
15. Wells RW, Blennerhassett MG. Persistent and selective effects of inflammation on smooth muscle cell contractility in rat colitis. Pflugers Arch 2004;448:515-24.
16. Martinsson T, Ljung T, Rubio C, Hellström PM. Beneficial effects of ropivacaine in rat experimental colitis. J Pharmacol Exp Ther 1999;291:642-7.
17. Khan I, Oriowo MA. Mechanism underlying the reversal of contractility dysfunction in experimental colitis by cyclooxygenase-2 inhibition. Inflammopharmacology 2006;14:28-35.
18. 2+ channels and its reversal by NF-κB inhibitors in Crohn's colitis model. Am J Physiol 2003;285:G483-93.
19. Bou-Fersen AM, Anim JT, Khan I. Experimental colitis is associated with ultrastructural changes in inflamed and uninflamed regions of the gastrointestinal tract. Med Princ Pract 2008;17:190-6.
20. Snape WJ Jr, Kao HW. Role of inflammatory mediators in colonic smooth muscle function in ulcerative colitis. Dig Dis Sci 1988;33 Suppl 3:65S-70S.
21. Myers BM, Martin JS, Dempsey DT, Parkman HP, Thomas RM, Ryan JP. Acute experimental colitis decreases colonic circular smooth muscle contractility in rats. Am J Physiol 1997;273:G928-36.
22. Hosseini JM, Goldhill JM, Bossone C, Pineiro-Carrero V, Shea-Donohue T. Progressive alterations in circular smooth muscle contractility in TNBS-induced colitis in rats. Neurogastroenterol Motil 1999;11:347-56.
23. 2+ mobilization in circular muscle cells of the inflamed colon. Am J Physiol 2000;278:G234-42.
24. Natale L, Piepoli AL, De Salvia MA, De Salvatore G, Mitolo CI, Marzullo A, et al. Interleukins-1β and 6 induce functional alteration of rat colonic motility: an in vitro study. Eur J Clin Invest 2003;33:704-12.
25. 2+-sensitization in attenuated carbachol-induced contraction of,the colon in a rat model of colitis. Eur J Pharmacol 2008;579:365-73.
26. Sato K, Ohkura S, Kitahara Y, Ohama T, Hori M, Sato M, et al. Involvement of CPI-17 down-regulation in the dysmotility of the colon from dextran sodium sulfate-induced experimental colitis in a mouse model. Neurogastroenterol Motil 2007;19:504-14.
27. Aube AC, Blottiere HM, Scarpignato C. Inhibition of acetylcholine induced intestinal motility by interleukin 1beta in the rat. Gut 1996;39:470-4.
28. Vrees MD, Pricalo VE, Potenti FM, Cao W. Abnormal motility in patients with ulcerative colitis Arch Surg 2002;137:439-46.
29. Ohama T, Hori M, Sato K, Ozaki H, Karaki H. Chronic treatment with interleukin-1b attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle. J Biol Chem 2003;278:48794-804.
30. Cao W, Fiocchi C, Pricolo VE. Production of IL-1b, hydrogen peroxide and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis. Am J Physiol 2005;289:C1408-16.
31. Tomita R, Tanjoh K, Fzuisaki S, Ikeda T, Koshinaga T. The role of interleukin-1 beta (IL-1beta) in the normal human colon in vitro. Hepatogastroenterology 2005;52:464-8.
32. Hu W, Mahavadi S, Li F, Murthy KS. Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1beta. Am J Physiol 2007;293:C1991-2000.
33. Lodato RF, Khan AR, Zembowicz MJ, Weisbrodt NW, Pressley TA, Li Y, et al. Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide. Am J Physiol 1999;276:G1356-62.
34. Khan I, Al-Awadi FM. Colonic muscle enhances the production of interleukin-1b messenger RNA in experimental colitis. Gut 1997;40:307-12.
35. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
36. Ishiguro Y. Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. J Gastroenterol 1999;34:66-74.
37. Bachmeier B, Nerlich AG, Iancu CM, Cilli M, Schleicher E, Vené R, et al. The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 2007;19:137-52.
38. Weber WM, Hunsaker LA, Roybal CN, Bobrovnikova-Marjon EV, Abcouwer SF, Royer RE, et al. Activation of NFkappaB is inhibited by curcumin and related enones. Bioorg Med Chem 2006;14:2450-61.
39. Yeh CH, Chen TP, Wu YC, Lin YM, Jing Lin P. Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion. J Surg Res 2005;125:109-16.